Do you want to read an article? Please log in or register.
Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial
Heart, Artery and Coronary DiseasesThrombosis and Stroke
Related content
Heart, Artery and Coronary Diseases
Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial
Am Heart J.
Ward R, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Mahaffey KW, Norgren L, Vemulapalli S, Povsic TJ, Mehta R, Hiatt WR, Patel MR, Jones WS
doi: 10.1016/j.ahj.2019.11.007.
Heart, Artery and Coronary Diseases
Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial
J Am Coll Cardiol.
Low Wang CC, Blomster JI, Heizer G, Berger JS, Baumgartner I, Fowkes FGR, Held P, Katona BG, Norgren L, Jones WS, Lopes RD, Olin JW, Rockhold FW, Mahaffey KW, Patel MR, Hiatt WR; EUCLID Trial Executive Committee and Investigators
doi: 10.1016/j.jacc.
Heart, Artery and Coronary DiseasesMyocardial Infarction
Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
JAMA Cardiol.
Olivier CB, Mulder H, Hiatt WR, Jones WS, Fowkes FGR, Rockhold FW, Berger JS, Baumgartner I, Held P, Katona BG, Norgren L, Blomster J, Patel MR, Mahaffey KW
doi: 10.1001/jamacardio.
Cardiovascular Risk and DiseasesHeart, Artery and Coronary DiseasesTherapy and Intervention
Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial
Circ Cardiovasc Interv
Rymer JA, Mulder H, Narcisse DI, Rockhold F, Hiatt WR, Fowkes FG, Baumgartner I, Berger JS, Katona BG, Mahaffey K, Norgren L, Blomster JI, Jones WS, Patel MR
doi: 10.1161/CIRCINTERVENTIONS.120.009326
Heart, Artery and Coronary DiseasesMyocardial InfarctionThrombosis and Stroke
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Lancet.
Anand SS, Bosch J, Eikelboom JW, Connolly SJ, Diaz R, Widimsky P, Aboyans V, Alings M, Kakkar AK, Keltai K, Maggioni AP, Lewis BS, Störk S, Zhu J, Lopez-Jaramillo P, O'Donnell M, Commerford PJ, Vinereanu D, Pogosova N, Ryden L, Fox KAA, Bhatt DL, Misselwitz F, Varigos JD, Vanassche T, Avezum AA, Chen E, Branch K, Leong DP, Bangdiwala SI, Hart RG, Yusuf S; COMPASS Investigators
doi: 10.1016/S0140-
Heart, Artery and Coronary Diseases
Clinical factors associated with peripheral artery disease in patients with documented coronary artery disease: A post hoc analysis of the COMPASS trial
Atherosclerosis
Gouda P, Ramasundarahettige C, Anand S, Muhlhoffer E, Berkowitz S, Fox KA, Eikelboom J, Welsh R
doi: 10.1016/j.atherosclerosis.2021.07.003
Heart, Artery and Coronary DiseasesTherapy and Intervention
Impact of Coronary Artery Disease on 30-Day and 1-Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta-Analysis
J Am Heart Assoc.
Sankaramangalam K, Banerjee K, Kandregula K, Mohananey D, Parashar A, Jones BM, Jobanputra Y, Mick S, Krishnaswamy A, Svensson LG, Kapadia SR
doi: 10.1161/
Heart, Artery and Coronary DiseasesThrombosis and Stroke
Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin
J Am Coll Cardiol.
Eikelboom JW, Bosch JJ, Connolly SJ, Shestakovska O, Dagenais GR, Hart RG, Leong DP, O'Donnell M, Fox KAA, Bhatt DL, Cairns JA, Tasto C, Berkowitz SD, Cook Bruns N, Muehlhofer E, Diaz R, Maggioni AP, Yusuf S
doi: 10.1016/j.jacc.2019.07.065.
COMMENTED
Heart, Artery and Coronary DiseasesLipid-Lowering Drugs
Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of a Randomized Clinical Trial
★ 3
Recommended and commented by
Prof. Dr Isabella Sudano, Faculty Member
doi: 10.1161/CIRCULATIONAHA.120.046524.